FORECAST Trial: Interview with Dr. Campbell Rogers
Donut of Destiny
English - August 24, 2021 16:00 - 25 minutes - 17.8 MBEducation Health & Fitness Medicine Homepage Download Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Aortic Valve Calcium Scoring
Next Episode: New chest pain guidelines
Alastair and Praveen are joined by Dr. Campbell Rogers, CMO and executive VP at HeartFlow, to discuss the recently-published FORECAST trial. What are the economic and clinical outcomes of selective FFRct use in stable chest pain? Tune in and enjoy!